Publication | Open Access
ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy
32
Citations
19
References
2019
Year
ABCB1 mutation is associated with higher neurotoxicity of taxane-based chemotherapy. It also predicts shorter PFS for NSCLC in paclitaxel-based treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1